Scottsdale, Arizona 7/2/2008 2:30:35 AM
News / Finance

QualityStocks.net News – China Yongxin Pharmaceuticals, Inc. (CYXN.OB) Signs Exclusive Franchise Agreement with Multi-Billion Dollar Drug Chain

At http://www.qualitystocks.net/ you can sign up for Quality Stock's Daily Newsletter to find out what Small-Cap and Micro-Cap online Investment Newsletters are interested in, plus hear about the latest news from our clients as well as other publicly traded companies.

 

We would like to highlight China Yongxin Pharmaceuticals, Inc. (OTCBB: CYXN). The company was founded in 1993 as the Changchun Yongxin Dirui Medical Co., Ltd. (Yongxin), a wholesale drug distributor. Its products include Chinese traditional medicines, Chinese traditional medical teas, chemical pharmaceutical preparations, natural health products, healthy food, cosmetics, and medical equipment.

 

In the company’s recent news,

 

China Yongxin Pharmaceuticals has signed a 10-year franchise agreement with one of the world’s largest US-based drug chains. The name of the chain was not released, but the agreement will allow China Yongxin to use the drug chain’s brand name in operating drug chain stores in Jilin Province.

 

According to the terms of the agreement, the company will have exclusive rights to the brand name in operations in Jilin Province, which includes the City of Changchun. China Yongxin will convert 87 of its existing stores in Jilin Province to branded stores during the first three years of the contract, as well as operate at least half of its new stores under this brand. By the end of the year, China Yongxin expects to have at least eight branded stores in operation, either through conversions or new store openings.

 

The contract gives China Yongxin a couple of added benefits as well. First, the multi-billion dollar drug chain gives them the marketing power of a globally recognized brand of one of the world’s leading pharmacy franchisors. Finally, it will help with the planned expansion of China Yongxin into additional Chinese provinces because the agreement helps to confirm its status as one of the fastest-growing retail drug store chains in China.

 

Yongxin Liu, China Yongxin Pharmaceutical’s chairman and CEO, commented, “The decision by our new partner to choose our company to represent its brand of retail drug stores, beginning with Jilin Province, testifies to the industry’s recognition and acceptance of our company’s proven model of vertical integration and aggressive, yet systematic growth. We believe that the ongoing expansion of our retail drug chain stores, wholesale distribution and manufacturing subsidiaries should position us as one of the fastest-growing players in one of the world’s largest drug and pharmaceutical markets in the world.”

 

About QualityStocks

 

QualityStocks.net, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks.net is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.

 

To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/

 

Please see disclaimer on QualityStocks.net website: http://Disclaimer.QualityStocks.net 

 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.